Home » Court Rejects Teva’s Arguments, Invalidates Its Crestor Patent
Court Rejects Teva’s Arguments, Invalidates Its Crestor Patent
A federal appeals court has affirmed a lower court decision invalidating Teva’s stabilizing formulation patent for blockbuster AstraZeneca cholesterol drug Crestor.
Generic Line
Generic Line
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May